Introduction
White spot disease (WSD) is at currently the most serious viral disease in cultivated shrimp, which causes widespread losses in the shrimp industry around the world. The causative agent is commonly known as the white spot syndrome virus (WSSV) due to its main clinic sign of 'white spots' in the exomesoderm under the carapace. Once introduced, the viruses spread rapidly as a result of its extremely strong virulence. Although it is found mainly in shrimps, it also infects other aquatic organisms including crabs and crayfish (Luo et al., 1996; Chen et al.,1997; Flegel, 1997) .
The WSSV was originally classified as an unassigned member of the Baculoviridae because of its bacilliform, enveloped, rod-shaped morphology (Francki et al., 1991) . However, it was later listed as unclassified due to the lack of adequate molecular information (Murphy et al., 1995) . In 2001, the whole 305 kb genome sequence was reported (Van Hulten et al., 2001a; Yang et al., 2001) . Analysis indicated that it contained 181 open reading frames (ORFs), some of which were similar to known viral genes or eukaryotic genes. However, most frames encoded the putative proteins without any homology to any known protein (Yang et al., 2001) . Owing to the lack of a similarity to any existing virus family, the WSSV was allocated to a new virus family Nimaviridae and the genus Whispovirus (http://www.ncbi.nlm.nih.gov/ICTV/).
In 2000, two major structural protein genes of the WSSV (vp28 and vp26) were identified (Van Hulten et al., 2000a) , which was followed by genes for ribonucleotide reductase, endonuclease, protein kinase and other structural proteins (Van Hulten et al., 2000b; Liu et al., 2001; Witteveldt et al., 2001; Chen et al., 2002; Van Hulten et al., 2002; Zhang et al., 2002) . All these reports have provided a great deal of information on the molecular basis of viral replication and infection. However, up to now, the mechanism of virus entry and spread into the shrimp cells is poorly understood, which makes control of the WSSV infection quite difficult. The most critical step of a viral infection is cell attachment. Therefore, determining the binding mechanism of the WSSV to shrimp cells and the identification of the attachment-related proteins are essential for understanding the procedure of a viral infection.
It is well known that envelope proteins play very important roles in a viral infection in many viral species. For human viruses such as the measles virus and vaccinia virus, envelope proteins acting as cell surface binding proteins can bind to cells and initiate a viral infection (Mass et al., 1990; Lambert et al., 1996; Fayolle et al., 1999; Li et al., 2002) . For the animal virus duck HBV, the envelope protein L helps the virus translocate to the cell membrane by specific morphogenesis (Guo et al., 1997) . Apparently, the envelope proteins of the WSSV also fulfill the same functions. Therefore, it reasonable to assume that these envelope proteins play an important role in the mechanism of a viral infection.
A previous study suggested that the envelope protein, VP28, was involved in a systemic infection of shrimp using an in vivo neutralization experiment (Van Hulten et al., 2001b) . The unique study on function of VP28 suggests that it might be responsible for the attachment to a specific yet unidentified cell surface receptor. Regarding the biological properties of VP28, there are five potential sites for N-linked glycosylation, two sites for O-glycosylation and nine possible phosphorylation sites within the protein. However, there is a strong hydrophobic region present at the N-terminus of VP28, including a putative transmembrane region (Van Hulten et al., 2000a) . The biological structures of VP28 suggest that it might play a role as attachment protein. In order to examine the cellular and molecular mechanisms that contribute to the WSSV binding to target cells, an in vitro neutralization test was performed in a primary cell culture and a unique recombinant chimeric form of VP28-EGFP (VP28 fused with enhanced green fluorescence protein) for a virus-cell binding test was developed. These results indicate the role of VP28 in the whole viral infection procedure.
Material and Methods
Virus production and DNA extraction The WSSV used in this study was isolated from infected Penaeus monodon shrimps obtained from the Yellow Sea aquatic institute, Qingdao City, China. The infected tissue was homogenized and centrifuged, and the supernatant was filtered with a 0.45 µm filter to separate the pathogens. The filtrate was then injected into healthy Freshwater Crayfish Procambarus clarkii to initiate an infection. Three to four days post-infection, the gills, stomach, epithelia and antennal glands were mixed with a cold TN buffer (20 mM TrisHCl, 400 mM NaCl, pH 7.4), homogenized, and then centrifuged to pellet the cellular debris. The supernatant containing the virus was further centrifuged at 80,000 × g for 1.5 h at 4 o C on a 30-60% continuous sucrose gradient. The virus band was collected, andcentrifuged at 120,000 × g for 1.5 h to pellet the virus.
After virus purification, the WSSV genomic DNA was extracted using the Phenol-Chloroform method (Sambrook et al., 1989) , and purified using a Qiagen DNA Purification Kit according to the manufacturers instructions.
Plasmid construction
The forward primer 5'-CCG GAA TTC ATG GAT CTT TCT TTC -3' with an EcoR I site and the reverse primer, 5'-CCC AAG CTT TTA CTC GGT CTC AGT GCC -3,' with a Hind III site were used for the PCR amplification of the VP28 gene using WSSV DNA as a template. The PCR product was cloned into the pET28a vector (Novagen) to obtain the recombinant plasmid pET28+28. An egfp cDNA fragment from pEGFP-N1 (Clontech) was subsequently sub-cloned into pET28+28 i.e. VP28 is fused upstream of the egfp gene, and was used to construct the final recombinant plasmid that was designated, pET28+28G.
Expression and purification of recombinant protein After the recombinant plasmids had been transformed into E.coli BL21, IPTG (isopropylthio--D-galactoside, a 200 µg/ml final concentration) was added in order to induce the expression of the recombinant protein and SDS-PAGE was used to detect the expressed proteins. The samples containing the expressed proteins were used for further purification using a TALON Metal Affinity Resin Kit (Clontech) according to the instruction manual. The purified fractions were collected using a Model 2110 collector (Bio-Rad) and analyzed by SDS-PAGE.
Preparation of polyclonal antibody The VP28 Antigen (5 µg) was mixed with Freunds adjuvant (Sigma) and injected into the rabbits once every 2 weeks over an 8-week period. Four days after the last injection, the rabbits were exsanguinated to collect the antisera. The titers of the antiserum were 1 : 20000 by an enzymelinked immunosorbent assay (ELISA) (Sambrook et al., 1989) .
Primary shrimp cells culture
The lymphoid organs were obtained from a fresh adult P. monodon (100 g), and then washed. The lymphoid organs were minced into fragments as small as possible, which were then filtered and transferred to wells in a 24-well plate, and 1 ml of the culture medium containing 2 × L-15 (Invitrogen) supplemented with 15% FCS (fetal calf serum), 1% glucose, 5 g/L NaCl, 1,00 IU/ml penicillin, 1,00 µg/ml streptomycin, 5 µg/ml gentamicin was added to each well. The plate was then sealed and incubated at 28 o C until 70-80% confluent monolayers had formed. The detail procedure is reported elsewhere (G. Yi et al., 2003) .
Binding assay of target protein on cell surface
The primary shrimp cells prepared were adsorbed on the 24-well plate until a monolayer had formed, and medium was then removed. The cells were washed by phosphate buffered saline (PBS ) at different pH (4.0-8.0, 1.0-gradient, 10 mM sodium phosphate buffer, 0.8% NaCl, adjust pH with hydrochloric acid or sodium hydroxide to pH 4.0-8.0) at 37 o C for 5 min. Following the pH treatment, 200 µl of the fusion proteins, VP28-EGFP (about 50 µg), was added to a single well containing the primary cells. After adsorption for 1 h at room temperature, the rest of the non-adsorbed solution was moved and each well was washed twice with pH 7.0 PBS in order to remove the remaining proteins. This was followed by adding 300 µl of PBS. In parallel with the chimeric protein, VP28-EGFP, the purified EGFP protein was followed as a control (the purified EGFP protein was kindly provided by Dr. Yao Lunguang in our lab). The green-fluorescence on the cell surface was examined using phase contrast microscopy (Olympus) under a 488 nm excitation wavelength.
Extraction of membrane proteins and Western blot analysis
After the binding assay, the cells were moved into an ice-cold 0.85% NaCl solution, and minced in 250 mM sucrose, 5 mM Hepes/Tris, pH 7.5, homogenized and centrifuged. The supernatants were centrifuged at 100,000 × g for 60min in order to sediment the membrane proteins, which were then resuspended in 250 mM sucrose, 5 mM Hepes/Tris, pH 7.5. The protein concentration was estimated by measuring the optical densities (ODs) at 280 nm.
After membrane proteins had been subjected to the SDS-PAGE gel, the proteins were transferred onto a PVDF membrane (Roche) in electroblotting buffer (25 mM Tris, 190 mM glycine, 20% methanol) for 3 h. The membrane was immersed in a blocking buffer (3% BSA, 20 mM Tris, 0.9% NaCl, 0.1% Tween 20, pH 7.2) at 4 o C overnight followed by incubation with a polyclonal mouse anti-His · tag IgG (Sigma) for 3 h. HRP (horseradish peroxidase)-conjugated mouse anti-His · tag IgG goat anti-mouse IgG (Sigma) and the substrate solution (4-chloro-1-naphthol, Sigma) were used for detection.
Laser scanning confocal microscopy The primary shrimp cells were grown on a glass coverslip and 100 µl of VP28-EGFP was mixed with the cell monolayer at pH 6.0. After 2 h, the cells were examined using Leica laser confocal scanning microscopy for fluorescence at an excitation wavelength of 488 nm.
Competitive ELISA After a coating with 1 × 10 4 cells at 4 o C for 4 h, the serially dilutions of the purified VP28 proteins (containing His · tag) and 1 × 10 3 pfu/ml of the WSSV were added simultaneously into a different single well of a microtiter plate (adjust pH to 6.0 with acid PBS). The VP28 proteins were allowed to bind to the cells for 1 h at 28 o C. In a parallel experiment, the VP28 concentration was kept stable (100 ng/ml) but the WSSV were serially diluted. The other parallel experiment used a different dilution of VP28 (no WSSV). After binding for 1 h, ELISA was performed according to the standard protocol (Sambrook et al., 1989) using horseradish peroxidase (HRP)-conjugated mouse antiHis · tag (1/10,000 in bovine serum albumin (BSA), Sigma) and a tetramethyl benzidine (TMB) substrate (2 mg/ml TMB from Sigma Chemical Co., Saint Louis in 1 M sodium acetate, 4H 2 O 2 ). The optical density (OD) was twice measured at 405 nm using the shrimp cells as a negative control.
Virus infections and blocking assay Approximately 2 × 10
5 pfu of the WSSV was serially diluted in 2 ml of PBS in order to determine the best concentration for plaque quantitation. Subsequently, a different dilution of the polyclonal antibody against VP28 were mixed with an equal volume of the WSSV (at the concentration for plaque quantitation) for 1 h at 37 o C before being added to the confluent monolayers of the primary shrimp cells in a 24-well plate (500 µl per well). After adsorption for 1 h at room temperature, the wells were washed twice with a L-15 culture medium to remove the unassociated virus, which were then overlaid with a mixture of agarose and the L-15 medium supplemented with 2% fetal calf serum (FCS) in a volume of 500 µl. After the agarose had been cooled and hardened, the plate was sealed and incubated at 28 o C. After 48 h, the plaques were quantified using phase contrast microscopy (Olympus).
Results
Expression of VP28 and VP28-EGFP The vp28 gene and the vp28-egfp fusion gene were cloned into the pET28a vector, which was expressed as the His · tag fusion proteins. After incubation at 37 o C, the expressed proteins, both induced and non-induced, were analyzed by SDSPAGE (Fig. 1A) . A band (approximately 25 kDa) corresponding to the His · tag-VP28 fusion protein was observed in the induced bacteria containing pET28+28 (Fig. 1A, lane 3) . No protein was found at the same position in the induced E.coli containing pET28a and the non-induced E.coli carrying pET28+28 (Fig. 1A, lanes  2 and 4) . In another procedure, the chimeric protein, VP28-EGFP, was detected by the green fluorescence (Fig. 1C and  D) . In this study, the EGFP protein was fused downstream of the VP28 protein, and driven by the same promoter. Therefore, when the fluorescence from GFP protein could be detected, it was concluded that the VP28 was also expressed. The results shown in Fig. 1 indicate that the VP28 protein and the chimeric protein, VP28-EGFP, were expressed. The induced products were further purified using a TALON Metal Affinity Resin Kit affording the purified proteins, His · tag-VP28 (Fig. 1B, lane 2) and His · tag-VP28-EGFP.
VP28 can bind to shrimp cells with pH dependence
The assumption that VP28 can bind to the shrimp cells as an envelope protein is reasonable. This assumption was demonstrated using the chimeric protein VP28-EGFP as an indicator to detect the in vitro binding procedure. Interestingly, at pH 6.0, the fluorescence could easily be detected at 1 h post-adsorption in the VP28-EGFP-treated cells (Fig. 2c) . However, at pH 7.0, VP28 was weakly bound to the shrimp cells (Fig. 2d) . In addition, no fluorescence was detected in the cells at other pHs (Fig. 2a, b and e) . This indicates that the binding of VP28 to the cells is pH dependent and pH 6.0 is the suitable binding condition. Similarly, no fluorescence was observed in the EGFP-treated control groups (data not shown). This result shows that VP28 binds to shrimp cells, but not EGFP. The membrane proteins after adsorption were extracted for the Western blot assay. The clear band suggested that VP28-EGFP was strongly bound to the cells 1 h after adsorption (Fig. 3, lane 3) , This result further demonstrated that VP28 could bind to the cell membrane.
VP28 binding on cell membrane is transported to the cytoplasm
In order to investigate the event of post-binding, laser scanning confocal microscopy was used to observe the VP28-treated cells (at pH 6.0) from 0.5 h to 5 h after attachment. Surprisingly, the position of the fluorescence changed with the increasing binding time. The fluorescence conglomerated on the membrane surfaces at 0.5 h postadsorption (Fig. 4A ). However, with the time extension, the position of the fluorescence was changed. Fig. 4B shows an image at 3 h post-adsorption, from which the chimeric protein VP28-EGFP could easily be seen in the whole cytoplasm. This result indicated that the VP28 expressed in E.coli could not only bind to the cells but could also enter the cytoplasm. This indicates a possible process of viral infection, i.e. WSSV was recognized and was bound to a putative receptor on the shrimp cells membrane mediating by VP28. The virus then penetrated or was endocytosed into the cytoplasm. It then became uncoated and the virions were released.
VP28 can compete with WSSV to bind to cells
In order to further clarify the relationship between VP28 and WSSV, and to demonstrate that the VP28 binding to cells is not only selective but is also specific, a competitive ELISA assay was performed with the purified VP28 and WSSV. VP28 at concentration of 200 ng per ml gave the maximum absorbance of 0.508. Fig. 5 shows an increase in the number of bound proteins with increasing protein concentration. This means that there might be a stronger binding ability with the higher protein concentration. However, the absorbance value did not increase further when the protein concentration was > 200 ng per ml, indicating that the saturation had been reached.
In a parallel experiment, 1000 pfu/ml of the WSSV and different VP28 concentrations were simultaneously added into the cells in respective wells. The absorbances were measured after 1 h. Interestingly, the binding specificity was lower (Fig.  5, curve 4) than the corresponding non-WSSV treated cells (Fig. 5, curve 3) . Similarly, when VP28 was kept at 200 ng per ml, the OD value decreased with increasing WSSV concentration (Fig. 5, curve 5 ). This suggests that VP28 could compete with the WSSV to specifically bind to the cells.
VP28 polyclonal antibody can strongly block viral infection in cell culture
A plaque reduction neutralization test (PRNT) in the cell cultures was performed to determine the inhibition ability of the VP28 polyclonal antibody to the WSSV. The results revealed that visible plaque could easily be measured in the 24-well plates at a 10 3 virus dilution Fig. 1 . Expression and purification of the VP28 and VP28-EGFP proteins. SDS-PAGE (12% Coomassie brilliant blue-stained) was used to detect the the VP28 protein expression, but VP28-EGFP was detected by the green fluorescence using phase contrast microscopy under a 488 nm excitation wavelength because the EGFP protein is a good luminiferous indicator. (A). SDS-PAGE gel of VP28 expressed in the E. coli BL21. Lane 2 is a bacteria containing the vector pET28 as a negative control, Lane 4 is a non-induced E. coli BL21 containing the recombinant plasmid pET28+28, lane 3 is induced E. coli BL21 containing pET28+28, lane 1 is the marker. The arrow indicates the location of VP28. (B). After purification using the TALON Metal Affinity Resin, the VP28 protein was also detected by 12% Coomassie brilliant blue-stained SDS-PAGE. The arrow indicated the location of the purified VP28 protein. (C) is a glass photograph of the bacteria expressing VP28-EGFP and (D) is a fluorescence photo. C and D were taken from the same field. It is clear that the fluorescence is from where the bacteria aggregated i.e. the egfp gene is rightly expressed. The vp28 is driven by the same promoter as the egfp gene and it is fused upstream of the egfp gene. Therefore, the VP28 protein is also expressed.
corresponding to a concentration of approximately 100 ng per well. The results (Fig. 6A) suggest that the polyclonal antibodies could inhibit a virus infection to some degree at a concentration of approximately 1 × 10 5 dilution. On the other hand, the infection inhibition efficiency could be qualitatively compared using the cytopathic effect (CPE) of the different test groups 36 h after infection (Fig. 6 , B, C and D). After being treated with the VP28 polyclonal antibody, the cells were largely intact and their forms remained regular. However, the positive group showed a typical CPE including cell turgidity, cytonecrosis and cell rupture. Therefore, the VP28 polyclonal antibody targets the neutralization sites on the virus and blocks the infection process.
Discussion
This study identified the envelope protein, VP28, of the WSSV that binds to shrimp cells, and also demonstrated this protein with a significant role in the virus-cell interaction. Using the VP28 polyclonal antibody, it was confirmed that this antibody could neutralize the virus and block the viral infection. In addition, the binding to cells competitive with the virus indicated that VP28 might bind with similar but unidentified receptors on the cell surface. In addition, the microscopy results provided evidence of the binding of the VP28-cells.
Plaque reduction neutralization tests are usually used to identify the role of the envelope proteins or their domains on the infection process (Volkman et al., 1985; Galmiche et al., 1999) . Indeed, if the major envelope proteins or the domains related to the infection were neutralized, the morphological characteristics of the virus particle would change correspondingly, which would be followed by a failure to bind to the cell receptors and prevent a viral infection. In this study, the antibody against VP28 could inhibit the plaque formation of the WSSV i.e. it could inhibit a WSSV infection by changing the topology of viral morphogenesis. This means that VP28 plays an important role in the systemic infection process. However, the neutralization of viral infectivity by antibodies is a complex and poorly understood phenomenon. The antibodies could neutralize the antigenic epitopes related to the attachment to the cells, and could also inhibit the fusion to the cell membrane, which is then responsible for the loss of infectivity (Volkman et al., 1985; Ramsey et al., 1998; Sunyach et al., 1999) . The various mechanisms provide possible explanations for the neutralization of the envelope proteins. The neutralization test suggested that VP28 participated in the infection process of the WSSV.
In addition in vitro experiments demonstrated the actual role of VP28 in viral infection process. The ELISA result showed that the VP28 expressed in E.coli could bind to shrimp cells and the binding ability was concentration dependent. Simultaneously, the WSSV could reduce the binding ability of VP28 to the cells, which means that VP28 might compete with the WSSV for similar receptor sites existing on the cell surface, and that VP28 is possibly responsible for the viral attachment to shrimp cells. Generally, the cell attachment of microorganisms, including viruses, is often defined by the ability of a surface molecule to bind to the specific target cell surface receptors (Tyler et al., 1996) . Viral binding is followed by membrane fusion, which leads to a productive infection in permissive hosts. The microscopy results highlighted the specific binding process of VP28 to the cells. The images of VP28 post-adsorption at different times showed that VP28 appeared at different times in different regions within the cells from the cell membrane to the cytoplasm. It is well known that it is difficult for macromolecules such as proteins to penetrate the cell (A) Curve 3 shows the average OD values at different VP28 concentrations, the serially diluted purified VP28 were added into a different single well of the microtiter plate, after the VP28 binding to the cells for 1 h, the optical density was measured at 450 nm. Curve 1 shows cells control (non-VP28) and curve 2 shows the cell control that the virus did not infect. This curve shows that the binding of VP28 to the cells is concentration dependent. Curve 4 shows the average OD values at different VP28 concentrations when 1 10 membrane. However, this study found that VP28-EGFP exists in the cytoplasm. It could be explained that VP28 entering the shrimp cells by imitating the mechanism of virus penetration or endocytosis by reason of the similar structure with the WSSV. From this result, the infection process could be clarified as follows: First, the VP28 on viral surface was either bound to the shrimp cells and mediated the viral infection in binding directly to the receptor specific to the WSSV or promoted the internalization by activating a fusogenic site, which was followed the WSSV entering the cells, which was then uncoated in the cytoplasm. Hence VP28 could be observed not only on the cell surface but also in the cytoplasm.
This study found that the binding of VP28 to the cells was pH dependent. Indeed, for many viral species, the pH is sensitive to virus-cell binding. Gong et al. (1990) revealed that the 14-KDa envelope protein of the vaccinia virus mediated virus-cell fusion only at an acidic pH. Blissard et al. (1992) reported that the envelope protein GP64 of AcMNPV was sufficient to mediate the pH dependent membrane fusion. This suggests that pH 6.0 was the best pH for WSSV-shrimp cell binding.
Generally, the virus entering the cytoplasm and then initiating virus replication is a complicated procedure. There are always many proteins as a complex (also some single proteins) that participate during the entry process. As the Epstein-Barr virus enters B cells, a complex of three glycoproteins, gH, gL, and gp42, are needed for penetration. However, the gH protein is also an attachment protein that recognizes the cell receptor (Sara et al., 2000) . Likewise, the Pseudorabies virus glycoprotein gis responsible for membrane fusion but is also essential for the virus to penetrate into the cells (B Peeters et al., 1992) . In this study, VP28 could not only bind to the cells but also enters the cytoplasm during the process of WSSV attachment and penetrates shrimp cells.
The VP28-defective recombinant WSSV is very difficult to construct due to the lack of a cell line and a suitable screening system for recombinant viruses. In this situation, in vitro binding experiments are ideal methods for examining the virus-cell binding. However, Chen et al. (1996) demonstrated that the envelope protein of the dengue virus was responsible for binding to the target cells via a chimeric protein. As for the vaccinia virus, a 32-kDa envelope protein synthesized in E.coli could bind with specificity to the cell surface (Lai et al., 1991) . For the foamy virus, the recombinant envelope protein can also bind to the host cells (Ottmar et al., 1999) . In this study, the recombinant chimeric protein, VP28-EGFP, was used to study the cell binding properties. The results highlighted the strong binding ability of the VP28-EGFP fusion protein specifically to shrimp cells. Therefore, that VP28 is responsible for binding to the shrimp cells.
The confirmation of the envelope protein for a viral infection can provide important molecular targets both for the development of vaccines and for the development of therapeutic strategies based on the blockage of target cell binding. However, further studies aimed at identifying both the envelope protein domains responsible for binding to the target cell and the target cell receptor molecules should lead to an enhanced understanding of the pathophysiology of the WSSV. 
